400 related articles for article (PubMed ID: 16213009)
1. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
Shaw AR
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
[TBL] [Abstract][Full Text] [Related]
2. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
3. HPV vaccine MedImmune/GlaxoSmithKline.
Billich A
Curr Opin Investig Drugs; 2003 Feb; 4(2):210-3. PubMed ID: 12669384
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for preventing HPV-related anogenital infection and neoplasia.
Ferris DG
J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555
[TBL] [Abstract][Full Text] [Related]
5. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.
Ault KA
Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S26-31. PubMed ID: 16729901
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases.
Villa LL
Vaccine; 2006 Mar; 24 Suppl 1():S23-8. PubMed ID: 16194583
[TBL] [Abstract][Full Text] [Related]
7. Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL.
Reinis M
Curr Opin Mol Ther; 2004 Apr; 6(2):206-11. PubMed ID: 15195933
[TBL] [Abstract][Full Text] [Related]
8. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
[TBL] [Abstract][Full Text] [Related]
11. A human papillomavirus vaccine.
Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):65-6. PubMed ID: 16977280
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection: an old disease, a new vaccine.
Giles M; Garland S
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
Williamson AL; Passmore JA; Rybicki EP
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccines.
Stanley MA
Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
[TBL] [Abstract][Full Text] [Related]
15. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
16. Introducing human papillomavirus vaccines - questions remain.
Paavonen J; Lehtinen M
Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
[TBL] [Abstract][Full Text] [Related]
17. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
Mahoney MC
J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cervical cancer through papillomavirus vaccination.
Frazer IH
Nat Rev Immunol; 2004 Jan; 4(1):46-54. PubMed ID: 14704767
[TBL] [Abstract][Full Text] [Related]
19. Prevention strategies of cervical cancer in the HPV vaccine era.
Bosch X; Harper D
Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
[No Abstract] [Full Text] [Related]
20. [Biology of the papillomavirus infections: V. Vaccine developments].
Seilles E; Riethmuller D; Mougin C
Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]